Skip to main content
CRVL logo

CRVL · Corvel Corp

Track CRVL — free
$70.36 +0.22 (+0.31%) At close · Aug 26
Market Cap
$3.54B
Shares
50.52M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$70.36 Open$70.05 Day$68.05–70.99 52W close$46.00–90.34 Avg vol 30d172K Short int1.4M · 2.8% float · 7.3d Short vol52% Last earningsNov 1, 2022 DataDec 2024–Aug 2026 Filing10-Q · Aug 6

Raw chart and full-history price indicators begin at the captured split on Dec 26, 2024; bars on opposite sides are not compared.

Up next

FQ2-27 quarter ends
~Sep 30, 2026 Est
filed Aug 6, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol High
Market backdrop VIX 15.2 · calm Equity put/call 0.64
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +14%
above
Price vs 50-day avg +12%
above
RSI (14) 69
neutral
MACD trend Positive
52-week position 55%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +13%
trailing
6-month return +28%
trailing
YTD return +4%
this year
Relative strength +16%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $63 › 200d $62 — 50d above 200d
Institutional flow Accumulating
+2% holders QoQ · +41 funds added
Insider flow Distributing
Net -$834.1K over 90 days · 100% sells
Short interest Rising
2.77% of float · ▲ +16.3% MoM · 7.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
288 holders — mid 3-yr range
Squeeze score 69
elevated · 0–100
Fundamentals
Excellent
Revenue growth +7%
Y/Y
Gross margin 24%
expanding
EPS growth +17%
Y/Y
Free cash flow $110.3M
Balance sheet $233.1M
net cash
Quant / Vol
risk profile
High
Volatility 42%
annualized · 1-yr
Max drawdown −49%
past year
ATR 3.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+14% Bullish
Price vs 50-day avg
+12% Bullish
RSI (14)
69 Neutral
MACD trend
Positive Bullish
52-week position
55% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $63 › 200d $62 — 50d above 200d
Institutional flow Accumulating
+2% holders QoQ · +41 funds added
Insider flow Distributing
Net -$834.1K over 90 days · 100% sells
Short interest Rising
2.77% of float · ▲ +16.3% MoM · 7.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
288 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $46 Now $70 · 55% Range high $90
vs 200-day avg +14% vs 50-day avg +12%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Corporate systems costs as a percentage of general and administrative expense 44% the three months ended June 30, 2026 filing
Field indirect costs 32% the three months ended June 30, 2026 filing
General and administrative expense as a percentage of revenues 11% the three months ended June 30, 2026 filing
Increase in salaries 9% the three months ended June 30, 2026 filing
Increased average headcount 5% the three months ended June 30, 2026 filing
Network solutions services revenues $100.6M the three months ended June 30, 2026 filing
Patient management services revenues $159.3M the three months ended June 30, 2026 filing
Total new claims 8% the three months ended June 30, 2026 filing

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance Brokers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CRVL
Corvel Corp
this stock
$3.54B +4.0% +7.0% 31.2 2.8%
MRSH
Marsh & Mclennan Companies, Inc.
$92.61B +4.2% +10.3% 23.7 1.5%
AON
Aon plc
$75.69B +0.3% +7.7% 19.7 1.6%
AJG
Arthur J. Gallagher & Co.
$69.71B +2.4% +10.1% 45.1 2.3%
WTW
Willis Towers Watson PLC
$32.57B +4.4% -2.2% 21.7 3.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
288
% held
54.8%
Net QoQ
+608.3K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
271
View
Short & Settlement
Short Interest Rising
Shares short
1.4M
Days to cover
7.3d
Change
+195.8K sh
View
Short Volume
Short vol %
52%
As of
Aug 26, 2026
Short Total
View
Fails to Deliver
FTD shares
538
Value
$33.2K
As of
Jul 20, 2026
View
Off-Exchange
Off-exchange %
33.3%
Week of
Jul 20, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$834.1K
Buyers / Sellers
0 / 3
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$958.5M
Net income (FY)
$110.3M
EPS diluted
$2.14
View
Buybacks
Authorized
shares 117.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 11, 2026
This year
9
View
Proposed Sales
Value
$486.5K
Shares
6.8K
Filed
Aug 24, 2026
View
Earnings & Events
Earnings Calls
Last call
Nov 1, 2022
View

Performance

Raw-price comparisons begin at the captured split on Dec 26, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
CRVL -0.6% +13.0% +28.3% +17.2% +4.0%
SPY -0.4% +5.0% +12.4% +2.6% +12.3%
vs SPY -0.2% +8.0% +15.9% +14.6% -8.4%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
shares 117.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 874866 CUSIP 221006109 13F (30d) 232 filings 232 filers Visit website Investor relations